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Abstract  
Introduction: Early diagnosis of pulmonary thromboembolism (PTE) is crucial in clinical medicine. Many 
para-clinical measurements are used to diagnose PTE.  
Objective: The present study was conducted to evaluate platelet indices in terms of diagnosing PTE. 
Methods: The present case-control study was conducted between May 2015 to July 2016 with 173 patients 
suspected of PTE in the emergency wards of Shahid Madani Hospital and Imam Reza Hospital affiliated to 
Tabriz University of Medical Sciences, Iran. The patients’ platelet indices were checked upon admission and 
they were evaluated in terms of diagnosing PTE. Platelet indices included mean platelet volume (MPV), platelet 
distribution width (PDW) and plateletcrit (PL-CR). PTE was diagnosed in 125 out of the 173 patients. Platelet 
indices were also compared between two groups. 
Results: No statistically significant differences were observed between the two groups in term of demographic 
variables (p>0.05). MPV was found to be 10.38±8.59 in the case group and 9.46±1.11 in the controls (p˃0.05). 
PDW was also found to be 12.86±5.57 in the case group and 12.32±2.48 in the controls (p>0.05). Moreover, 
PL-CR was found to be 22.59±7.32 in the case group and 21.97±8.16 in the controls (p>0.05). 
Conclusion: According to the obtained results, platelet indices do not increase in PTE. They cannot be 
therefore used to diagnose PTE in suspected patients. 
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INTRODUCTION
PTE is a life threatening condition with a mortality 
of 25%-30%; nevertheless, the mortality can be 
decreased to 2%-8% if the disease is properly 
diagnosed (1). The main symptoms of this disease 
include respiratory distress, chest pain, lower 
arterial blood oxygen saturation, tachypnea and 
tachycardia (2). Although pulmonary artery 
angiography constitutes a gold standard for 
diagnosing PTE, other para-clinical techniques 
such as simple chest x-rays, electrocardiogram, 
arterial blood gas (ABG) test, color Doppler 
ultrasonography, ventilation/perfusion scan, CT 
pulmonary angiography (CTPA) and D-dimer test 
can be used (3). Research suggests that platelet 
activation plays a key role in patients with 
thrombotic problems, and the platelet activation 
process in PTE has been reported. An increase in 
MPV is a predictor factor for venous 
thromboembolism (VTE) with an unknown origin 
(4). Alidaei N. et al. found MPV to increase in PTE, 
and proposed a simple test to use in PTE patients 
(5). Song JE. et al. found high levels of platelets 
during chemotherapy to be a risk factor for PTE in 
cancer patients (6). Given that platelets play a key 
role in developing thrombosis, variations in 
platelet indices appear to be effective in forming or 
intensifying the coagulation process and 
thromboembolism in patients with PTE, and 
platelet indices can be used to diagnose PTE (5). 
Given the possibility of platelet activation in the 
incidence of VTE, the present study was conducted 
to evaluate the diagnostic value of platelet indices 
in patients with PTE. 
METHODS 
Study design and participants 
The present case-control study was conducted 
from May 2015 to July 2016 with 173 patients 
suspected of PTE with a complaint of chest pain 
presenting to Shahid Madani Hospital and Imam 
Reza Hospital affiliated to Tabriz University of 
Medical Sciences, Tabriz, Iran. The minimum 
sample size was calculated as 43 in each group 
using G*Power with α=0.05, β=0.95 and a 
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confidence interval of 0.95, while primary MPV 
data were obtained from the study of Alidaei N. 
(PTE group: 10.57±1.08 fl and control group: 
9.80±0.86 fl) (5). The inclusion criterion comprised 
an acute dyspnea score of over 3 based on the 
Wells’ criteria. The exclusion criteria consisted of 
having a history of blood diseases, i.e. 
myeloproliferative disorder and idiopathic 
thrombocytopenic purpura (ITP), hypothyroidism, 
pulmonary embolism and DVT, kidney failure, 
obesity (BMI>30) and rheumatic diseases, i.e. 
ankylosing spondylitis and rheumatoid arthritis. 
Convenience sampling was used to select the 
subjects. The present study was approved by the 
Ethics Committee of Tabriz University of Medical 
Sciences. 
Data Gathering 
After performing the primary evaluation of the 
eligible patients, blood samples were collected, and 
platelet indices were examined using an automated 
hematology analyzer (made in Japan). The patients 
were then admitted and evaluated for PTE. All the 
patients also underwent CT angiography (Siemens, 
Germany, 64 slices) of pulmonary arteries, and the 
reports were provided by a faculty member of 
Tabriz University of Medical Sciences as the 
radiologist. The patients were then divided into a 
case group comprising 125 patients with PTE and a 
control group comprising 48 patients without PTE. 
Statistical analysis 
The data collected were analyzed in SPSS-16. 
Furthermore, descriptive tests were used to 
describe the data. The Kolmogorov-Smirnov test 
was also used to investigate the distribution 
normality of the data, and the independent t-test to 
compare the quantitative data, and the Chi-squared 
test to compare the qualitative data. P<0.05 was set 
as the level of statistical significance. 
RESULTS 
Out of 173 patients with dyspnea and suspected of 
PTE, 125 were diagnosed with PTE. No significant 
relationships were observed between the two 
groups in terms of gender, age and BMI (Table 1). 
Table 2 compares platelet indices between the two 
groups. Given the lack of any statistically significant 
differences between the two groups in term of 
platelet indices, the receiver operator curve (ROC) 
was not applicable to determining the sensitivity, 
specificity and cut off point of MPV, PDW and PL-
CR for the diagnosis of PTE. 
DISCUSSION 
As a serious disease in emergency wards, PTE 
constitutes the cause of 100,000 deaths in the US 
(7, 8). Given its high mortality and potential 
complications, the prompt diagnosis and treatment 
of this disease is crucial (9).  
Research suggests an increase in MPV and PDW 
levels in PTE and the need for the use of MPV for 
diagnosing PTE (9). In addition, MPV and PDW can 
be used to determine the intensity of pulmonary 
embolism (10). Studies have shown that 
thrombocytosis is tightly related to the increased 
risk of acute symptomatic PTE, and helps with the 
prediction of its mortality and severity (11). 
According to Icli A. et al., MPV increases in patients 
with deep vein thrombosis (DVT), and high levels 
of MPV can predict the risk of PTE in these patients 
(12). Yardan T. et al. showed that MPV and 
MPV/platelet ratio are associated with the 
intensity of the clinical symptoms of PTE, and that 
lower rates of MPV and MPV/platelet ratio are 
related to lower risks of PTE (13). Huang J. et. al. 
found that MPV and PDW levels are significantly 
higher in patients with PTE, and that using MPV 
combined with D-Dimer helps diagnose PTE (9). 
In contrast to the references cited, the present 
research did not suggest statistically significant 
differences between the patients with PTE and 
those without this condition in term of platelet 
indices, and did not observe any increases in PDW, 
Table 1: The comparison of demographic variables between the two groups 
p Control (n=48) Case (n=125) Variable 
>0.05 
  Gender 
20 (41.6%) 66 (52.8%) Male 
28 (58.4%) 59 (47.2%) Female 
>0.05 60.66±23.88 59.85±16.53 Age (year) 
>0.05 26.26±3.26 26.12±2.52 Body mass index 
 
Table 2: The comparison of platelet indices in case and control groups 
p Control (n=48) Case (n=125) Variable 
>0.05 253192.31±127185.53 242486.49±106885.75 Platelet count 
>0.05 9.46±1.11 10.38±8.59 MPV 
>0.05 12.32±2.48 12.86±5.57 PDW 
>0.05 21.97±8.16 22.59±7.32 PL-CR 
MPV: mean platelet volume; PDW: Platelet distribution width; PL-CR: plateletcrit 
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PL-CR and MPV in the patients with PTE; A 
significant increase in MPV and a decrease in the 
number of platelets have been reported in 
literature (8).   
CONCLUSIONS 
In contrast to previously-conducted studies, the 
present findings suggest that platelet indices do not 
increase in patients with PTE. These findings are 
recommended to be evaluated by conducting 
further research with larger sample sizes. 
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